New activity is brewing for Fonar ( (FONR) ). The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder vote. This form gives shareholders all the information they need to develop an informed vote. Read on to learn more about the proposed company action.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
FONAR has called a special shareholder meeting for May 28, 2026, to vote on a merger that would see FONAR Acquisition Sub, Inc. combine with the company, making FONAR a wholly owned subsidiary of FONAR, LLC, an entity controlled by CEO Timothy Damadian. The deal, structured as a going-private transaction, offers $19.00 per common and Class B share, $6.34 per Class C share and $10.50 per Class A preferred share in cash, representing substantial premiums to prior trading prices and leading to a Nasdaq delisting if approved.
An acquisition group of 57 insiders and affiliated investors, already controlling about 42% of FONAR’s voting power, has signed voting agreements supporting the merger and plans to roll their equity into the new private parent. A special committee of independent directors, advised by external legal and financial advisers, unanimously deemed the transaction fair to unaffiliated shareholders, and the board is urging investors to vote in favor, with approval contingent on both an overall majority and a separate majority of disinterested shareholders.
Spark’s Take on FONR Stock
According to Spark, TipRanks’ AI Analyst, FONR is a Neutral.
The score is driven primarily by weakening financial performance (sharp TTM revenue decline, margin and cash-conversion pressure, and a loss-making MRI equipment segment) offset by a stable balance sheet and constructive technical momentum. Valuation is moderate but lacks dividend support.
To see Spark’s full report on FONR stock, click here.
More about Fonar
FONAR Corporation is a Delaware-based medical technology company focused on magnetic resonance imaging systems and related diagnostic services. Through its majority-owned subsidiary Health Diagnostics Management, it operates imaging centers, positioning the company within the U.S. diagnostic imaging and healthcare services market.
Average Trading Volume: 60,925
Technical Sentiment Signal: Buy
Current Market Cap: $117.9M
See more insights into FONR stock on TipRanks’ Stock Analysis page.